Skip to main content
Erschienen in: World Journal of Surgery 1/2012

01.01.2012

Clinicopathologic Features and Risk Factors for Extrahepatic Recurrences of Hepatocellular Carcinoma After Curative Resection

verfasst von: Toshiya Ochiai, Hisashi Ikoma, Kazuma Okamoto, Yukihito Kokuba, Teruhisa Sonoyama, Eigo Otsuji

Erschienen in: World Journal of Surgery | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of this study was to clarify the clinicopathologic features of hepatocellular carcinoma (HCC) patients with extrahepatic metastasis after the removal of primary HCC, and the risk factors of extrahepatic recurrence.

Methods

Clinicopathologic data were available for 264 HCC patients who underwent an R0 resection for HCC. Twenty-six patients who developed extrahepatic recurrence during the follow-up period (EXT group) were compared with patients who remained free from recurrence for at least 5 years after resection (n = 46) (No R group) or had only intrahepatic recurrences (n = 193) (INT group). We also estimated the risk factors of extrahepatic recurrence and survival in these 26 patients.

Results

There were significant differences in primary tumor size, patient’s age, findings in the noncancerous portion, macroscopic type, ductal invasion, intrahepatic metastasis, hepatic involvement and curability of primary tumor, treatment for recurrent tumor, and prognosis between the EXT group and the other groups. Extrahepatic recurrence was significantly associated with six factors by univariate analyses: age, indocyanine green (ICG) 15-min retention rate, tumor size, hepatic involvement of primary tumor, type of hepatectomy, and TNM stage, of which tumor size was an independent risk factor. Resection of recurrent tumor was the only independent favorable factor for survival of patients with extrahepatic recurrence.

Conclusions

HCC patients with extrahepatic recurrence had advanced primary tumors and poor prognosis. HCC patients with primary tumors larger than 60 mm were predicted to develop extrahepatic recurrence. Resection of recurrent tumor can improve the prognosis of HCC patients with extrahepatic recurrence.
Literatur
1.
Zurück zum Zitat Belghiti J, Panis Y, Farges O et al (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214:114–117PubMedCrossRef Belghiti J, Panis Y, Farges O et al (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214:114–117PubMedCrossRef
2.
Zurück zum Zitat Balsells J, Charco R, Lazaro JL et al (1996) Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 83:758–761PubMedCrossRef Balsells J, Charco R, Lazaro JL et al (1996) Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 83:758–761PubMedCrossRef
3.
Zurück zum Zitat Chan KM, Yu MC, Wu TJ et al (2009) Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. World J Gastroenterol 15:5481–5488PubMedCrossRef Chan KM, Yu MC, Wu TJ et al (2009) Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. World J Gastroenterol 15:5481–5488PubMedCrossRef
4.
Zurück zum Zitat Taketomi A, Toshima T, Kitagawa D et al (2010) Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 17:2740–2746PubMedCrossRef Taketomi A, Toshima T, Kitagawa D et al (2010) Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 17:2740–2746PubMedCrossRef
5.
Zurück zum Zitat Yuki K, Hirohashi S, Sakamoto M et al (1990) Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 66:2174–2179PubMedCrossRef Yuki K, Hirohashi S, Sakamoto M et al (1990) Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 66:2174–2179PubMedCrossRef
6.
Zurück zum Zitat Belghiti J, Regimbeau JM, Durand F et al (2002) Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 49:41–46PubMed Belghiti J, Regimbeau JM, Durand F et al (2002) Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 49:41–46PubMed
7.
Zurück zum Zitat Ikai I, Arii S, Kojiro M et al (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101:796–802PubMedCrossRef Ikai I, Arii S, Kojiro M et al (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101:796–802PubMedCrossRef
8.
Zurück zum Zitat Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161:346–350PubMed Makuuchi M, Hasegawa H, Yamazaki S (1985) Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 161:346–350PubMed
9.
Zurück zum Zitat Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304PubMedCrossRef Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9:298–304PubMedCrossRef
10.
Zurück zum Zitat Liver Cancer Study Group of Japan (2003) General rules for the clinical and pathological study of primary liver cancer, 2nd English edn. Kanehara, Tokyo, pp 13–28 Liver Cancer Study Group of Japan (2003) General rules for the clinical and pathological study of primary liver cancer, 2nd English edn. Kanehara, Tokyo, pp 13–28
11.
Zurück zum Zitat Sobin LH, Wittekind CH (eds) (1997) TNM classification of malignant tumours, 5th edn. Wiley-Liss, New York, pp 81–83 Sobin LH, Wittekind CH (eds) (1997) TNM classification of malignant tumours, 5th edn. Wiley-Liss, New York, pp 81–83
12.
Zurück zum Zitat Kokudo N, Makuuchi M (2009) Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterol 44(Suppl 19):119–121PubMedCrossRef Kokudo N, Makuuchi M (2009) Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterol 44(Suppl 19):119–121PubMedCrossRef
13.
Zurück zum Zitat Arii S, Sata M, Sakamoto M et al (2010) Management of hepatocellular carcinoma: report of consensus meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res 40:667–685PubMedCrossRef Arii S, Sata M, Sakamoto M et al (2010) Management of hepatocellular carcinoma: report of consensus meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res 40:667–685PubMedCrossRef
14.
Zurück zum Zitat Wang J, Xu LB, Liu C, Pang HW, Chen YJ, Ou QJ (2010) Prognostic factors and outcome of 438 Chinese patients with hepatocellular carcinoma underwent partial hepatectomy in a single center. World J Surg 34:2434–2441. doi:10.1007/s00268-010-0664-4 PubMedCrossRef Wang J, Xu LB, Liu C, Pang HW, Chen YJ, Ou QJ (2010) Prognostic factors and outcome of 438 Chinese patients with hepatocellular carcinoma underwent partial hepatectomy in a single center. World J Surg 34:2434–2441. doi:10.​1007/​s00268-010-0664-4 PubMedCrossRef
15.
Zurück zum Zitat Sonoyama T, Ochiai T, Hironaka T et al (2003) Predictors of postoperative diffuse recurrence of hepatocellular carcinoma. Hepatogastroenterology 50:1078–1084PubMed Sonoyama T, Ochiai T, Hironaka T et al (2003) Predictors of postoperative diffuse recurrence of hepatocellular carcinoma. Hepatogastroenterology 50:1078–1084PubMed
17.
Zurück zum Zitat Sasaki A, Kai S, Endo Y et al (2007) Hepatitis B virus infection predicts extrahepatic metastasis after hepatic resection in patients with large hepatocellular carcinoma. Ann Surg Oncol 14:3181–3187PubMedCrossRef Sasaki A, Kai S, Endo Y et al (2007) Hepatitis B virus infection predicts extrahepatic metastasis after hepatic resection in patients with large hepatocellular carcinoma. Ann Surg Oncol 14:3181–3187PubMedCrossRef
18.
Zurück zum Zitat Ogawa M, Yamamoto T, Kudo S et al (2004) Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma. Hepatol Res 29:228–234PubMedCrossRef Ogawa M, Yamamoto T, Kudo S et al (2004) Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma. Hepatol Res 29:228–234PubMedCrossRef
19.
Zurück zum Zitat Liu Y, Wu MC, Qian GX et al (2002) Detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction. Hepatobiliary Pancreat Dis Int 1:72–76PubMed Liu Y, Wu MC, Qian GX et al (2002) Detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction. Hepatobiliary Pancreat Dis Int 1:72–76PubMed
20.
Zurück zum Zitat Hasegawa K, Takayama T, Ijichi M et al (2006) Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology 44:865–891CrossRef Hasegawa K, Takayama T, Ijichi M et al (2006) Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology 44:865–891CrossRef
21.
Zurück zum Zitat Takayama T, Sekine T, Makuuchi M et al (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial. Lancet 356:802–807PubMedCrossRef Takayama T, Sekine T, Makuuchi M et al (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial. Lancet 356:802–807PubMedCrossRef
22.
Zurück zum Zitat Yoon YS, Kim HK, Kim J et al (2010) Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 17:2795–2801PubMedCrossRef Yoon YS, Kim HK, Kim J et al (2010) Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 17:2795–2801PubMedCrossRef
23.
Zurück zum Zitat Poon RT, Fan ST, O’Suilleabhain CB et al (2002) Aggressive management of patients with extrahepatic and intrahepatic recurrence of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg 195:311–318PubMedCrossRef Poon RT, Fan ST, O’Suilleabhain CB et al (2002) Aggressive management of patients with extrahepatic and intrahepatic recurrence of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg 195:311–318PubMedCrossRef
24.
Zurück zum Zitat Aramaki M, Kawano K, Kai T et al (1999) Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection. Hepatogastroenterology 46:2931–2934PubMed Aramaki M, Kawano K, Kai T et al (1999) Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection. Hepatogastroenterology 46:2931–2934PubMed
25.
Zurück zum Zitat Jang JW, Kay CS, You CR et al (2009) Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Int J Radiat Oncol Biol Phys 74:412–418PubMedCrossRef Jang JW, Kay CS, You CR et al (2009) Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases. Int J Radiat Oncol Biol Phys 74:412–418PubMedCrossRef
26.
Zurück zum Zitat Hawkins MA, Dawson LA (2006) Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer 106:1653–1663PubMedCrossRef Hawkins MA, Dawson LA (2006) Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer 106:1653–1663PubMedCrossRef
27.
Zurück zum Zitat Katamura Y, Aikata H, Kimura Y et al (2010) Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases. J Gastroenterol Hepatol 25:1117–1122PubMedCrossRef Katamura Y, Aikata H, Kimura Y et al (2010) Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases. J Gastroenterol Hepatol 25:1117–1122PubMedCrossRef
28.
Zurück zum Zitat Hsu CH, Yang TS, Hsu C et al (2010) Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy inpatients with advanced hepatocellular carcinoma. Br J Cancer 102:981–986PubMedCrossRef Hsu CH, Yang TS, Hsu C et al (2010) Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy inpatients with advanced hepatocellular carcinoma. Br J Cancer 102:981–986PubMedCrossRef
Metadaten
Titel
Clinicopathologic Features and Risk Factors for Extrahepatic Recurrences of Hepatocellular Carcinoma After Curative Resection
verfasst von
Toshiya Ochiai
Hisashi Ikoma
Kazuma Okamoto
Yukihito Kokuba
Teruhisa Sonoyama
Eigo Otsuji
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 1/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1317-y

Weitere Artikel der Ausgabe 1/2012

World Journal of Surgery 1/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.